Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.

Rhodes, JM; Potter, BJ; Brown, DJ; Jewell, DP

Abstract:

Studies were undertaken to determine the incidence and nature of serum chemotaxis inhibitors in patients with Crohn's disease and ulcerative colitis. Sera from patients with active Crohn's disease were shown to contain chemotactic factor-directed inhibitory activity. The molecular size of the inhibitor estimated by gel filtration is similar to the 7S gamma-globulins and it is precipitable by 40% ammonium sulfate. Less marked inhibitory activity is present in the same fractions of sera from pa...

Expand abstract

Publication status:

Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Rhodes, J. M., Potter, B. J., Brown, D. J., & Jewell, D. P. (1982). Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis. Gastroenterology, 82(6), 1327–1334.

MLA Style

Rhodes, J. M., et al. “Serum Inhibitors of Leukocyte Chemotaxis in Crohn's Disease and Ulcerative Colitis.” Gastroenterology, vol. 82, no. 6, 1982, pp. 1327–34.

Chicago Style

Rhodes, JM, BJ Potter, DJ Brown, and DP Jewell. 1982. “Serum Inhibitors of Leukocyte Chemotaxis in Crohn's Disease and Ulcerative Colitis.” Gastroenterology 82 (6): 1327–34.
Tweet
Print